MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2022 International Congress

    A One-year follow-up study of effects of voltage/frequency Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) adjustments on speech intelligibility in Parkinson’s Disease (PD)

    N. Castillo-Triana, M. Camargo-Mendoza, O. Bernal-Pacheco (Bogotá, Colombia)

    Objective: To assess the relationship between along-1-year stimulation voltage(V)/frequency(F) adjustments and speech intelligibility (SI) in PD patients treated with STN-DBS. Background: Low V/F stimulation improves…
  • 2022 International Congress

    New-onset gait problems after bilateral STN-DBS for Parkinson’s disease: A systematic review

    J. Janssen Daalen, A. Selvaraj, D. Georgiev, B. Bloem, R. Bartels, R. Esselink, S. Vinke (Nijmegen, Netherlands)

    Objective: In this systematic review, we provide an overview of an underrecognized, but common side effect related to deep brain stimulation of the subthalamic nucleus…
  • 2022 International Congress

    Subthalamic beta bursts reflect the continuous stochastic fluctuations of ongoing oscillations in Parkinson’s disease

    J. Pardo-Valencia, C. Fernández-García, F. Alonso-Frech, G. Foffani (Móstoles, Spain)

    Objective: To test whether subthalamic beta bursts in Parkinson’s disease reflect the continuous stochastic fluctuations of an oscillatory random process. Background: Subthalamic beta oscillations in…
  • 2022 International Congress

    Low-dose lithium therapy associated with increased PBMC Nurr1 and SOD1 expression in Parkinson’s disease: a pilot study.

    T. Guttuso, JR., R. Shepherd, M. Tamano, M. Ramanathan, V. Frerichs, L. Frick (Williamsville, USA)

    Objective: To determine the effects of lithium therapy on blood-based biomarkers in Parkinson’s disease (PD). Background: Lithium has multiple neuroprotective actions and may account for…
  • 2022 International Congress

    Feasibility of in-person and remote delivery of Alexander technique course for care partners of people with neurodegenerative disease

    M. Gross, R. Cohen, J. Bellingham, P. Brisset, C. Condie, S. Lazaro, B. Mello, A. Abdelrahman, J. Becker, S. Smith, T. Moote, W. Trusty (Candler, USA)

    Objective: Test feasibility of in-person and remote delivery via Zoom of Alexander technique (AT) course to improve quality of life for care partners (CP) of…
  • 2022 International Congress

    Apathy in Parkinson’s disease: serum biochemical markers and clinical features

    LT. Li, Y. Qu, HL. Gao, YJ. Xiong, Z. Min, ZJ. Mao, JY. Li, QX. Qin, DL. Wang, JW. Zhao, Z. Xue (Wuhan, China)

    Objective: This study aims to explore clinical features and blood biochemical markers of apathy in PD. Background: Apathy is one of the most common non-motor…
  • 2022 International Congress

    Current Concepts in Physical Therapy and Rehabilitation Protocol for Camptocormia: An Unusual Case Report

    S. Calisgan, E. Calisgan, M. Ceylan, Y-E. Aktas (Manchester, United Kingdom)

    Objective: To investigate symptoms observed in patients with Parkinson’s Disease with camptocormia and prepare a protocol for physical therapy in addition to medical and surgical…
  • 2022 International Congress

    Audit of dysphagia care provided to Parkinson’s patients during acute hospital admission

    M. Khwaja, G. Desai, J. Murphy, A. Chatterjee (Reading, United Kingdom)

    Objective: To evaluate dysphagia recognition and management in Parkinson’s patients admitted to Royal Berkshire Hospital (RBH),Reading,UK according to National Confidential Enquiry into Patient Outcome and…
  • 2022 International Congress

    Motor decision-making in Parkinson’s disease

    L. Avanzino, B. Berret, E. Pelosin, M. Bove, T. Pozzo, A. Bisio (Genoa, Italy)

    Objective: The aim of this study is to test motor decision-making ability in Parkinson's disease (PD) in conditions with different biomechanical properties and levels of…
  • 2022 International Congress

    Color vision deficits in Parkinson’s disease are linked to brain abnormalities in attentional, fronto-pariental and visual networks

    M. Diez-Cirarda, A. Murueta-Goyena, A. Miscioscia, R. Del Pino, S. Teijeira, MA. Acera, O. Lucas-Jimenez, N. Ojeda, B. Tijero, JC. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)

    Objective: To analyze the relationship between color vision deficits in Parkinson’s disease (PD) and the integrity of the visual system, cognition and other relevant networks…
  • « Previous Page
  • 1
  • …
  • 310
  • 311
  • 312
  • 313
  • 314
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley